The Jason Lewis Lab

The Jason Lewis Lab

The Lewis lab research interests are focused on the development of radiopharmaceuticals for targeted diagnosis and treatment of cancer. By combining small- and biomolecule-based targeting agents with positron-emitting or therapeutic radioisotopes, we can interrogate molecular profiles of cancer using noninvasive nuclear imaging or treat tumors specifically with endoradiotherapy. Our research program is a molecular-imaging-based program focused on the targeting of nonstandard nuclides, with an emphasis on developing these novel radiopharmaceuticals for clinical translation. A few examples of our work are given below.

Learn more Arrow rightAn icon showing an arrow pointing to the right.
Pictured: Jason Lewis

Jason S. Lewis, PhD

Emily Tow Jackson Chair in Oncology


Research Focus

Radiochemist Jason Lewis develops molecular imaging agents for the imaging and therapy of cancer.


PhD, The University of Kent (UK)